Supramolecular nanosubstrate–mediated delivery system enables CRISPR-Cas9 knockin of hemoglobin beta gene for hemoglobinopathies

Journal: Science Advances

Published: 2020-10-01

DOI: 10.1126/sciadv.abb7107

Affiliations: 18

Authors: 25

Go to article
Institutions Share
California NanoSystems Institute (CNSI), United States of America (USA) 0.39
UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC), United States of America (USA) 0.10
University of Southern California (USC), United States of America (USA) 0.08
Department and Institute of Pharmacology, NYMU, Taiwan 0.07
Taipei Veterans General Hospital (TPEVGH), Taiwan 0.06
Anhui Academy of Agricultural Sciences (AHAAS), CAAS, China 0.04
Medical School, FOSU, China 0.04
Shenzhen People’s Hospital, China 0.04
National Chung Hsing University (NCHU), Taiwan 0.04
Center for Stem Cell and Translational Medicine, AHU, China 0.03
School of Life Sciences, AHU, China 0.03
Department of Pathology (DOP), SYSUCC, China 0.02
Precision Medicine Institute at The First Affiliated Hospital, SYSU, China 0.02
Department of Medical Research, TPEVGH, Taiwan 0.01
Genomics Research Center, Academia Sinica, Taiwan 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER